US Stock MarketDetailed Quotes

ATRA Atara Biotherapeutics

Watchlist
  • 8.380
  • +0.230+2.82%
Close Oct 15 16:00 ET
47.55MMarket Cap-214P/E (TTM)

Atara Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
79.84%-10.65M
22.94%-29.61M
28.64%-192.98M
11.38%-50.41M
21.08%-51.35M
17.46%-52.8M
54.54%-38.43M
-22.63%-270.43M
-65.98%-56.88M
-10.31%-65.06M
Net income from continuing operations
73.21%-19.05M
57.53%-31.75M
-20.95%-276.13M
18.94%-60.45M
17.00%-69.8M
-485.08%-71.11M
15.13%-74.77M
32.88%-228.3M
20.11%-74.57M
0.68%-84.09M
Operating gains losses
----
----
----
----
----
----
----
---50.24M
--0
--0
Depreciation and amortization
10.74%1.33M
14.58%1.39M
-14.58%4.83M
-3.98%1.21M
-11.69%1.21M
-16.48%1.2M
-23.70%1.21M
-39.51%5.65M
-49.56%1.26M
-40.91%1.37M
Other non cash items
-2.11%4.13M
-2.76%4.05M
85.40%16.8M
41.12%4.08M
56.60%4.34M
52.51%4.22M
556.62%4.16M
340.76%9.06M
302.93%2.89M
412.38%2.77M
Change In working capital
-409.23%-3.38M
-160.01%-11.73M
124.96%15.34M
-440.84%-7.28M
178.93%1.97M
102.15%1.09M
245.02%19.55M
-216.89%-61.47M
-94.83%2.14M
-91.84%707K
-Change in receivables
30,474.55%33.41M
-104.33%-1.73M
115.58%6.11M
15.08%-33.95M
-11.34%344K
-454.84%-110K
12,423.27%39.82M
-14,961.74%-39.24M
-3,953.96%-39.97M
--388K
-Change in inventory
-5.71%-2.67M
-69.90%-6.38M
-411.98%-8.12M
-96.41%-3.12M
--1.27M
---2.52M
---3.75M
---1.59M
---1.59M
--0
-Change in payables and accrued expense
-193.53%-11.52M
27.31%-2.26M
-391.55%-6.79M
-303.89%-5.45M
-44.20%5.69M
39.59%-3.92M
23.14%-3.11M
-65.25%2.33M
-30.28%2.67M
600.07%10.2M
-Change in other current assets
-30.15%1.96M
40.95%-1.62M
-16.18%1.32M
-90.82%515K
118.02%742K
11,096.00%2.8M
-5,472.55%-2.74M
-75.68%1.57M
-12.69%5.61M
-45,855.56%-4.12M
-Change in other current liabilities
-728.12%-10.41M
50.56%-2.42M
74.41%-1.43M
267.33%7.77M
-2,632.20%-5.98M
2,816.39%1.66M
-337.33%-4.89M
-645.07%-5.59M
-206.46%-4.65M
-28.70%236K
-Change in other working capital
-543.67%-14.16M
146.12%2.67M
227.93%24.26M
-32.73%26.94M
98.67%-100K
107.57%3.19M
37.80%-5.78M
-147.50%-18.96M
-9.81%40.05M
-385.83%-7.55M
Cash from discontinued investing activities
Operating cash flow
79.84%-10.65M
22.94%-29.61M
28.64%-192.98M
11.38%-50.41M
21.08%-51.35M
17.46%-52.8M
54.54%-38.43M
-22.63%-270.43M
-65.98%-56.88M
-10.31%-65.06M
Investing cash flow
Cash flow from continuing investing activities
-85.46%7.2M
345.00%14.72M
-38.97%123.87M
-80.58%9.94M
18.01%70.45M
55.48%49.48M
-109.98%-6.01M
811.83%202.96M
310.57%51.22M
4,899.75%59.7M
Net PPE purchase and sale
94.19%-29K
68.17%-127K
-101.32%-1.2M
-18.92%-44K
-93.94%-256K
-100.53%-499K
84.68%-399K
956.07%90.57M
98.50%-37K
96.58%-132K
Net investment purchase and sale
-85.54%7.23M
364.69%14.84M
11.28%125.06M
-80.51%9.99M
18.18%70.7M
181.24%49.98M
-108.93%-5.61M
242.24%112.38M
334.49%51.26M
1,084.73%59.83M
Cash from discontinued investing activities
Investing cash flow
-85.46%7.2M
345.00%14.72M
-38.97%123.87M
-80.58%9.94M
18.01%70.45M
55.48%49.48M
-109.98%-6.01M
811.83%202.96M
310.57%51.22M
4,899.75%59.7M
Financing cash flow
Cash flow from continuing financing activities
-168.79%-324K
10,172.77%24.14M
-96.21%2.01M
-95.32%1.51M
2.80%-208K
-59.29%471K
-98.82%235K
-48.93%53.08M
-37.26%32.29M
-100.45%-214K
Net issuance payments of debt
-9.91%-233K
27.24%-227K
-82.82%-947K
-76.23%-215K
-0.97%-208K
-68.25%-212K
-387.50%-312K
-103.94%-518K
-96.77%-122K
-232.26%-206K
Net common stock issuance
-29,952.00%-15.03M
3,708.44%24.37M
-90.24%2.14M
12.44%1.55M
--0
-117.39%-50K
-96.88%640K
-77.82%21.89M
-97.25%1.38M
--0
Proceeds from stock option exercised by employees
-84.87%113K
--0
-51.69%928K
-61.41%181K
--0
-42.93%747K
--0
-71.59%1.92M
-70.17%469K
-94.42%47K
Net other financing activities
92.86%-1K
93.55%-6K
-100.36%-107K
--0
--0
-366.67%-14K
87.08%-93K
2,462.41%29.79M
--30.57M
---55K
Cash from discontinued financing activities
Financing cash flow
-168.79%-324K
10,172.77%24.14M
-96.21%2.01M
-95.32%1.51M
2.80%-208K
-59.29%471K
-98.82%235K
-48.93%53.08M
-37.26%32.29M
-100.45%-214K
Net cash flow
Beginning cash position
-27.93%35.23M
-72.08%25.99M
-13.39%93.09M
-2.29%64.94M
-36.08%46.04M
-52.54%48.89M
-13.39%93.09M
-46.74%107.48M
-42.01%66.46M
-42.49%72.03M
Current changes in cash
-32.71%-3.77M
120.92%9.25M
-366.30%-67.1M
-246.27%-38.95M
438.95%18.89M
90.82%-2.84M
-890.39%-44.2M
84.74%-14.39M
473.73%26.63M
47.65%-5.57M
End cash Position
-31.67%31.46M
-27.93%35.23M
-72.08%25.99M
-72.08%25.99M
-2.29%64.94M
-36.08%46.04M
-52.54%48.89M
-13.39%93.09M
-13.39%93.09M
-42.01%66.46M
Free cash flow
79.97%-10.67M
23.41%-29.74M
29.28%-194.2M
11.36%-50.45M
20.80%-51.63M
18.49%-53.3M
55.44%-38.83M
-18.83%-274.62M
-54.94%-56.92M
-3.75%-65.19M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 79.84%-10.65M22.94%-29.61M28.64%-192.98M11.38%-50.41M21.08%-51.35M17.46%-52.8M54.54%-38.43M-22.63%-270.43M-65.98%-56.88M-10.31%-65.06M
Net income from continuing operations 73.21%-19.05M57.53%-31.75M-20.95%-276.13M18.94%-60.45M17.00%-69.8M-485.08%-71.11M15.13%-74.77M32.88%-228.3M20.11%-74.57M0.68%-84.09M
Operating gains losses -------------------------------50.24M--0--0
Depreciation and amortization 10.74%1.33M14.58%1.39M-14.58%4.83M-3.98%1.21M-11.69%1.21M-16.48%1.2M-23.70%1.21M-39.51%5.65M-49.56%1.26M-40.91%1.37M
Other non cash items -2.11%4.13M-2.76%4.05M85.40%16.8M41.12%4.08M56.60%4.34M52.51%4.22M556.62%4.16M340.76%9.06M302.93%2.89M412.38%2.77M
Change In working capital -409.23%-3.38M-160.01%-11.73M124.96%15.34M-440.84%-7.28M178.93%1.97M102.15%1.09M245.02%19.55M-216.89%-61.47M-94.83%2.14M-91.84%707K
-Change in receivables 30,474.55%33.41M-104.33%-1.73M115.58%6.11M15.08%-33.95M-11.34%344K-454.84%-110K12,423.27%39.82M-14,961.74%-39.24M-3,953.96%-39.97M--388K
-Change in inventory -5.71%-2.67M-69.90%-6.38M-411.98%-8.12M-96.41%-3.12M--1.27M---2.52M---3.75M---1.59M---1.59M--0
-Change in payables and accrued expense -193.53%-11.52M27.31%-2.26M-391.55%-6.79M-303.89%-5.45M-44.20%5.69M39.59%-3.92M23.14%-3.11M-65.25%2.33M-30.28%2.67M600.07%10.2M
-Change in other current assets -30.15%1.96M40.95%-1.62M-16.18%1.32M-90.82%515K118.02%742K11,096.00%2.8M-5,472.55%-2.74M-75.68%1.57M-12.69%5.61M-45,855.56%-4.12M
-Change in other current liabilities -728.12%-10.41M50.56%-2.42M74.41%-1.43M267.33%7.77M-2,632.20%-5.98M2,816.39%1.66M-337.33%-4.89M-645.07%-5.59M-206.46%-4.65M-28.70%236K
-Change in other working capital -543.67%-14.16M146.12%2.67M227.93%24.26M-32.73%26.94M98.67%-100K107.57%3.19M37.80%-5.78M-147.50%-18.96M-9.81%40.05M-385.83%-7.55M
Cash from discontinued investing activities
Operating cash flow 79.84%-10.65M22.94%-29.61M28.64%-192.98M11.38%-50.41M21.08%-51.35M17.46%-52.8M54.54%-38.43M-22.63%-270.43M-65.98%-56.88M-10.31%-65.06M
Investing cash flow
Cash flow from continuing investing activities -85.46%7.2M345.00%14.72M-38.97%123.87M-80.58%9.94M18.01%70.45M55.48%49.48M-109.98%-6.01M811.83%202.96M310.57%51.22M4,899.75%59.7M
Net PPE purchase and sale 94.19%-29K68.17%-127K-101.32%-1.2M-18.92%-44K-93.94%-256K-100.53%-499K84.68%-399K956.07%90.57M98.50%-37K96.58%-132K
Net investment purchase and sale -85.54%7.23M364.69%14.84M11.28%125.06M-80.51%9.99M18.18%70.7M181.24%49.98M-108.93%-5.61M242.24%112.38M334.49%51.26M1,084.73%59.83M
Cash from discontinued investing activities
Investing cash flow -85.46%7.2M345.00%14.72M-38.97%123.87M-80.58%9.94M18.01%70.45M55.48%49.48M-109.98%-6.01M811.83%202.96M310.57%51.22M4,899.75%59.7M
Financing cash flow
Cash flow from continuing financing activities -168.79%-324K10,172.77%24.14M-96.21%2.01M-95.32%1.51M2.80%-208K-59.29%471K-98.82%235K-48.93%53.08M-37.26%32.29M-100.45%-214K
Net issuance payments of debt -9.91%-233K27.24%-227K-82.82%-947K-76.23%-215K-0.97%-208K-68.25%-212K-387.50%-312K-103.94%-518K-96.77%-122K-232.26%-206K
Net common stock issuance -29,952.00%-15.03M3,708.44%24.37M-90.24%2.14M12.44%1.55M--0-117.39%-50K-96.88%640K-77.82%21.89M-97.25%1.38M--0
Proceeds from stock option exercised by employees -84.87%113K--0-51.69%928K-61.41%181K--0-42.93%747K--0-71.59%1.92M-70.17%469K-94.42%47K
Net other financing activities 92.86%-1K93.55%-6K-100.36%-107K--0--0-366.67%-14K87.08%-93K2,462.41%29.79M--30.57M---55K
Cash from discontinued financing activities
Financing cash flow -168.79%-324K10,172.77%24.14M-96.21%2.01M-95.32%1.51M2.80%-208K-59.29%471K-98.82%235K-48.93%53.08M-37.26%32.29M-100.45%-214K
Net cash flow
Beginning cash position -27.93%35.23M-72.08%25.99M-13.39%93.09M-2.29%64.94M-36.08%46.04M-52.54%48.89M-13.39%93.09M-46.74%107.48M-42.01%66.46M-42.49%72.03M
Current changes in cash -32.71%-3.77M120.92%9.25M-366.30%-67.1M-246.27%-38.95M438.95%18.89M90.82%-2.84M-890.39%-44.2M84.74%-14.39M473.73%26.63M47.65%-5.57M
End cash Position -31.67%31.46M-27.93%35.23M-72.08%25.99M-72.08%25.99M-2.29%64.94M-36.08%46.04M-52.54%48.89M-13.39%93.09M-13.39%93.09M-42.01%66.46M
Free cash flow 79.97%-10.67M23.41%-29.74M29.28%-194.2M11.36%-50.45M20.80%-51.63M18.49%-53.3M55.44%-38.83M-18.83%-274.62M-54.94%-56.92M-3.75%-65.19M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data